tirzepatide co Eli Lilly sues companies selling alternative versions of its weight loss drug Tirzepatide rollout reaches fewer than

The Muscle Loss Problem GLP-1 drugs cause significant muscle mass loss alongside fat loss studies suggest 3040% of weight lost is lean mass

The reason: most physicians test only TSH, and only flag values outside a wide reference range

Clinical trials show average weight loss of 15-20% of body weight within 52 weeks, though individual results vary

Whether the patient has diabetes or not, these drugs should be the first-line drugs for obesity (138)

PCOS, perimenopause, menopause, and postpartum recovery all change how your metabolism works, how your body holds fat, and how it responds to the things that used to work